Researchers discovered that Thymosin Beta-4 is one of the first genes expressed after cardiac injury, positioning it among the earliest molecular responses to tissue damage
Considering this essential mechanism responsible for various severe systemic diseases, this might fully substantiate the significance of BPC 157 therapy in the realization of the recovery of the essential vascular failure in the rats with ligated bile ducts, as before in the other occlusion/occlusion-like syndromes [12,13,14,15,16,20,22,23,24,25,31], and thereby the full therapy effect
TB-500 (thymosin beta-4 fragment) drives systemic cellular migration it mobilizes stem cells and actin rearrangement across the whole body
Unreconstituted lyophilized powder stores well at room temperature away from light and heat